Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/32052170/ below:

ESR/ERS statement paper on lung cancer screening

Review

Affiliations

• ¹ Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany. hans-ulrich.kauczor@med.uni-heidelberg.de.
• ² Central Pathology Laboratory, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
• ³ Department of Pneumology, Klinikum Emil von Behring, Berlin, Germany.
• ⁴ Department of Radiology, Policlinico Universitario Agostino Gemelli, Rome, Italy.
• ⁵ Intensive Care Unit, Korgialeneion-Benakeion General Hospital, Athens, Greece.
• ⁶ Otto Wagner Hospital Vienna, Vienna, Austria.
• ⁷ S.E.N.A. s.r.o, Prague, Czech Republic.
• ⁸ Community Health Association Romania, Bucharest, Romania.
• ⁹ Service de Pneumologie et Oncologie Thoracique, Hospices Civils de Lyon, Sud, Pierre Bénite, Lyon, CH, France.
• ¹⁰ Faculté de Médecine et de Maïeutique Lyon Sud - Charles Mérieux, Université Claude Bernard Lyon I, Oullins, France.
• ¹¹ Royal Brompton Hospital, London, UK.
• ¹² , Holstebro, Denmark.
• ¹³ Department of Health Care of Moscow, Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
• ¹⁴ Internal Medicine F, Rabin Medical Center, Petah Tikva, Israel.
• ¹⁵ Thoracic Cancer Unit, Rabin Medical Center, Petach Tiqwa, Israel.
• ¹⁶ European Lung Foundation, Sheffield, UK.
• ¹⁷ Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
• ¹⁸ Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal.
• ¹⁹ Tobacco Cessation Unit, CHCB University Hospital, Covilha, Portugal.
• ²⁰ ELF Advocacy, Tipton, UK.
• ²¹ Radiology Department, Cochin Hospital, APHP, Paris, France.
• ²² Section of Radiology, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy.
• ²³ Radiology, University Hospital of Antwerp, Edegem, Belgium.
• ²⁴ Image Sciences Institute, University Medical Centre, Utrecht, The Netherlands.
• ²⁵ Department of Radiology, Nijmegen Medical Centre, Nijmegen, The Netherlands.
• ²⁶ Pulmonology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium.
• ²⁷ Clinic of Social and Family Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.
• ²⁸ Center for Global Tobacco Control, Department of Society, Human Development and Health, Harvard School of Public Health, Boston, MA, USA.
• ²⁹ Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany.
• ³⁰ 7th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece.

• PMID: 32052170
• DOI: 10.1007/s00330-020-06727-7

Item in Clipboard

Review

Hans-Ulrich Kauczor et al. Eur Radiol. 2020 Jun.

• ¹ Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany. hans-ulrich.kauczor@med.uni-heidelberg.de.
• ² Central Pathology Laboratory, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
• ³ Department of Pneumology, Klinikum Emil von Behring, Berlin, Germany.
• ⁴ Department of Radiology, Policlinico Universitario Agostino Gemelli, Rome, Italy.
• ⁵ Intensive Care Unit, Korgialeneion-Benakeion General Hospital, Athens, Greece.
• ⁶ Otto Wagner Hospital Vienna, Vienna, Austria.
• ⁷ S.E.N.A. s.r.o, Prague, Czech Republic.
• ⁸ Community Health Association Romania, Bucharest, Romania.
• ⁹ Service de Pneumologie et Oncologie Thoracique, Hospices Civils de Lyon, Sud, Pierre Bénite, Lyon, CH, France.
• ¹⁰ Faculté de Médecine et de Maïeutique Lyon Sud - Charles Mérieux, Université Claude Bernard Lyon I, Oullins, France.
• ¹¹ Royal Brompton Hospital, London, UK.
• ¹² , Holstebro, Denmark.
• ¹³ Department of Health Care of Moscow, Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
• ¹⁴ Internal Medicine F, Rabin Medical Center, Petah Tikva, Israel.
• ¹⁵ Thoracic Cancer Unit, Rabin Medical Center, Petach Tiqwa, Israel.
• ¹⁶ European Lung Foundation, Sheffield, UK.
• ¹⁷ Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
• ¹⁸ Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal.
• ¹⁹ Tobacco Cessation Unit, CHCB University Hospital, Covilha, Portugal.
• ²⁰ ELF Advocacy, Tipton, UK.
• ²¹ Radiology Department, Cochin Hospital, APHP, Paris, France.
• ²² Section of Radiology, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy.
• ²³ Radiology, University Hospital of Antwerp, Edegem, Belgium.
• ²⁴ Image Sciences Institute, University Medical Centre, Utrecht, The Netherlands.
• ²⁵ Department of Radiology, Nijmegen Medical Centre, Nijmegen, The Netherlands.
• ²⁶ Pulmonology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium.
• ²⁷ Clinic of Social and Family Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.
• ²⁸ Center for Global Tobacco Control, Department of Society, Human Development and Health, Harvard School of Public Health, Boston, MA, USA.
• ²⁹ Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany.
• ³⁰ 7th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece.

• PMID: 32052170
• DOI: 10.1007/s00330-020-06727-7

Item in Clipboard

In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now. Reaching out to the potential participants (persons at high risk), optimal communication and shared decision-making will be key starting points. Furthermore, standards for infrastructure, pathways and quality assurance are pivotal, including promoting tobacco cessation, benefits and harms, overdiagnosis, quality, minimum radiation exposure, definition of management of positive screen results and incidental findings linked to respective actions as well as cost-effectiveness. This requires a multidisciplinary team with experts from pulmonology and radiology as well as thoracic oncologists, thoracic surgeons, pathologists, family doctors, patient representatives and others. The ESR and ERS agree that Europe's health systems need to adapt to allow citizens to benefit from organised pathways, rather than unsupervised initiatives, to allow early diagnosis of lung cancer and reduce the mortality rate. Now is the time to set up and conduct demonstration programmes focusing, among other points, on methodology, standardisation, tobacco cessation, education on healthy lifestyle, cost-effectiveness and a central registry.Key Points• Pulmonologists and radiologists both have key roles in the set up of multidisciplinary LCS teams with experts from many other fields.• Pulmonologists identify people eligible for LCS, reach out to family doctors, share the decision-making process and promote tobacco cessation.• Radiologists ensure appropriate image quality, minimum dose and a standardised reading/reporting algorithm, together with a clear definition of a "positive screen".• Strict algorithms define the exact management of screen-detected nodules and incidental findings.• For LCS to be (cost-)effective, it has to target a population defined by risk prediction models.

Keywords: Carcinoma, bronchogenic; Cost-benefit analysis; Early detection of cancer; Lung neoplasms; Tobacco use cessation.

PubMed Disclaimer

• ESR/ERS statement paper on lung cancer screening.

  Kauczor HU, Baird AM, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, Čepická B, Comanescu A, Couraud S, Devaraj A, Jespersen V, Morozov S, Nardi Agmon I, Peled N, Powell P, Prosch H, Ravara S, Rawlinson J, Revel MP, Silva M, Snoeckx A, van Ginneken B, van Meerbeeck JP, Vardavas C, von Stackelberg O, Gaga M; European Society of Radiology (ESR) and the European Respiratory Society (ERS). Kauczor HU, et al. Eur Respir J. 2020 Feb 12;55(2):1900506. doi: 10.1183/13993003.00506-2019. Print 2020 Feb. Eur Respir J. 2020. PMID: 32051182

• ESR/ERS white paper on lung cancer screening.

  Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS). Kauczor HU, et al. Eur Radiol. 2015 Sep;25(9):2519-31. doi: 10.1007/s00330-015-3697-0. Epub 2015 May 1. Eur Radiol. 2015. PMID: 25929939 Free PMC article.

• ESR/ERS white paper on lung cancer screening.

  Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS). Kauczor HU, et al. Eur Respir J. 2015 Jul;46(1):28-39. doi: 10.1183/09031936.00033015. Epub 2015 Apr 30. Eur Respir J. 2015. PMID: 25929956 Free PMC article.

• The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.

  Fintelmann FJ, Bernheim A, Digumarthy SR, Lennes IT, Kalra MK, Gilman MD, Sharma A, Flores EJ, Muse VV, Shepard JA. Fintelmann FJ, et al. Radiographics. 2015 Nov-Dec;35(7):1893-908. doi: 10.1148/rg.2015150079. Epub 2015 Oct 23. Radiographics. 2015. PMID: 26495797 Review.

• Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging.

  Pereira LFF, Santos RSD, Bonomi DO, Franceschini J, Santoro IL, Miotto A, Sousa TLF, Chate RC, Hochhegger B, Gomes Neto A, Schneider A, Araújo Neto CA, Escuissato DL, Prado GF, Costa-Silva L, Zamboni MM, Ghefter MC, Corrêa PCRP, Torres PPTES, Mussi RK, Muglia VF, Godoy I, Bernardo WM. Pereira LFF, et al. J Bras Pneumol. 2024 Mar 22;50(1):e20230233. doi: 10.36416/1806-3756/e20230233. eCollection 2024. J Bras Pneumol. 2024. PMID: 38536982 Free PMC article. Review.

• Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial.

  Cortés-Ibáñez FO, Johnson T, Mascalchi M, Katzke V, Delorme S, Kaaks R. Cortés-Ibáñez FO, et al. Transl Lung Cancer Res. 2023 Dec 26;12(12):2460-2475. doi: 10.21037/tlcr-23-548. Epub 2023 Dec 22. Transl Lung Cancer Res. 2023. PMID: 38205209 Free PMC article.

• Squamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss.

  Patel AJ, Hemead H, Jesani H, Bille A, Taniere P, Middleton G. Patel AJ, et al. Int J Mol Sci. 2024 Jul 26;25(15):8165. doi: 10.3390/ijms25158165. Int J Mol Sci. 2024. PMID: 39125735 Free PMC article.

• Deep Learning for Lung Cancer Detection on Screening CT Scans: Results of a Large-Scale Public Competition and an Observer Study with 11 Radiologists.

  Jacobs C, Setio AAA, Scholten ET, Gerke PK, Bhattacharya H, M Hoesein FA, Brink M, Ranschaert E, de Jong PA, Silva M, Geurts B, Chung K, Schalekamp S, Meersschaert J, Devaraj A, Pinsky PF, Lam SC, van Ginneken B, Farahani K. Jacobs C, et al. Radiol Artif Intell. 2021 Oct 27;3(6):e210027. doi: 10.1148/ryai.2021210027. eCollection 2021 Nov. Radiol Artif Intell. 2021. PMID: 34870218 Free PMC article.

• Clinical value of an electromagnetic navigation system for CT-guided percutaneous lung biopsy of peripheral lung lesions.

  Zhang Y, Huang H, Cao S, Teng J, Wang Y, Ling X, Zhou Y, Xu J, Li W, Zhong H. Zhang Y, et al. J Thorac Dis. 2021 Aug;13(8):4885-4893. doi: 10.21037/jtd-21-395. J Thorac Dis. 2021. PMID: 34527327 Free PMC article.

• Strategies to deliver smoking cessation interventions during targeted lung health screening - a systematic review and meta-analysis.

  Williams PJ, Philip KE, Alghamdi SM, Perkins AM, Buttery SC, Polkey MI, Laverty AA, Hopkinson NS. Williams PJ, et al. Chron Respir Dis. 2023 Jan-Dec;20:14799731231183446. doi: 10.1177/14799731231183446. Chron Respir Dis. 2023. PMID: 37311772 Free PMC article. Review.

1. 1. Ferlay J, Colombet M, Soerjomataram I et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387 - PubMed
2. 1. Malvezzi M, Carioli G, Bertuccio P et al (2017) European cancer mortality predictions for the year 2017, with focus on lung cancer. Ann Oncol 28:1117–1123 - PubMed
3. 1. World Bank (1999) Curbing the epidemic: governments and the economics of tobacco control (English). World Bank, Washington, DC
4. 1. Kauczor HU, Bonomo L, Gaga M et al (2015) ESR/ERS white paper on lung cancer screening. Eur Respir J 46:28–39 - PubMed - PMC
5. 1. Quaife SL, Vrinten C, Ruparel M et al (2018) Smokers’ interest in a lung cancer screening programme: a national survey in England. BMC Cancer 18:497 - PubMed - PMC

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3